Evidence map›Paper›PMID 27391159›Full record

ArticleOncotarget2016

Gelsolin-Cu/ZnSOD interaction alters intracellular reactive oxygen species levels to promote cancer cell invasion.

Lalchhandami Tochhawng, Shuo Deng, Ganesan Pugalenthi, Alan Prem Kumar, Kiat Hon Lim, Tuan Zea Tan, Henry Yang, Shing Chuan Hooi, Yaw Chong Goh, Sutherland K Maciver and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Is miR-21 A Therapeutic Target in Cardiovascular Disease?International journal of drug discovery and pharmacology · 2023
    Article
  5. Review
  6. Review
  7. Susceptibility of cytoskeletal-associated proteins for tumor progression.Cellular and molecular life sciences : CMLS · 2021
    Review
  8. Article
  9. Review
  10. Article
  11. MicroRNA and ROS Crosstalk in Cardiac and Pulmonary Diseases.International journal of molecular sciences · 2020
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 6 countries.

Lalchhandami TochhawngDepartment of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Shuo DengDepartment of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Ganesan PugalenthiBioinformatics Group, Bioscience Core Laboratory, King Abdullah University of Science and Technology (KAUST), Kingdom of Saudi Arabia.
Alan Prem KumarDepartment of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Kiat Hon LimDepartment of Pathology, Singapore General Hospital, Singapore.
Tuan Zea TanCancer Science Institute of Singapore, National University of Singapore, Singapore.
Henry YangCancer Science Institute of Singapore, National University of Singapore, Singapore.
Shing Chuan HooiDepartment of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Yaw Chong GohDepartment of General Surgery, Singapore General Hospital, Singapore.
Sutherland K MaciverCentre for Integrative Physiology, University of Edinburgh, United Kingdom.
Shazib PervaizDepartment of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Celestial T YapDepartment of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
National University of Singapore · SGKing Abdullah University of Science and Technology · SAMount Elizabeth Hospital · SGNational University Cancer Institute, Singapore · SGSingapore General Hospital · SGUniversity of Edinburgh · GBUniversity of North Texas · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The actin-binding protein, gelsolin, is a well known regulator of cancer cell invasion. However, the mechanisms by which gelsolin promotes invasion are not well established. As reactive oxygen species (ROS) have been shown to promote cancer cell invasion, we investigated on the hypothesis that gelsolin-induced changes in ROS levels may mediate the invasive capacity of colon cancer cells.Herein, we show that increased gelsolin enhances the invasive capacity of colon cancer cells, and this is mediated via gelsolin's effects in elevating intracellular superoxide (O2.-) levels. We also provide evidence for a novel physical interaction between gelsolin and Cu/ZnSOD, that inhibits the enzymatic activity of Cu/ZnSOD, thereby resulting in a sustained elevation of intracellular O2.-. Using microarray data of human colorectal cancer tissues from Gene Omnibus, we found that gelsolin gene expression positively correlates with urokinase plasminogen activator (uPA), an important matrix-degrading protease invovled in cancer invasion. Consistent with the in vivo evidence, we show that increased levels of O2.- induced by gelsolin overexpression triggers the secretion of uPA. We further observed reduction in invasion and intracellular O2.- levels in colon cancer cells, as a consequence of gelsolin knockdown using two different siRNAs. In these cells, concurrent repression of Cu/ZnSOD restored intracellular O2.- levels and rescued invasive capacity.Our study therefore identified gelsolin as a novel regulator of intracellular O2.- in cancer cells via interacting with Cu/ZnSOD and inhibiting its enzymatic activity. Taken together, these findings provide insight into a novel function of gelsolin in promoting tumor invasion by directly impacting the cellular redox milieu.

Indexed as

Caco-2 CellsCell Line, TumorColonic NeoplasmsGelsolinGene Expression ProfilingGene Expression Regulation, NeoplasticHCT116 CellsHeLa CellsHep G2 CellsHumansModels, MolecularNeoplasm InvasivenessProtein BindingProtein DomainsReactive Oxygen SpeciesRNA InterferenceGelsolinReactive Oxygen SpeciesSuperoxide Dismutase-1Urokinase-Type Plasminogen ActivatorantioxidantAutophagyCu/ZnSODcytoskeletongelsolininvasionROS

Identifiers

PMID27391159
PMCPMC5288152
OpenAlexW2468978217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.